<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Approach to upper gastrointestinal bleeding in children</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Approach to upper gastrointestinal bleeding in children</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Approach to upper gastrointestinal bleeding in children</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Xavier Villa, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Melvin B Heyman, MD, MPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Stephen J Teach, MD, MPH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Alison G Hoppin, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 26, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Upper gastrointestinal (UGI) bleeding (arising proximal to the ligament of Treitz in the distal duodenum) commonly presents with hematemesis (vomiting of red blood or coffee ground-like material) and/or melena (black, tarry stools). In comparison, hematochezia (bright red or maroon-colored blood or fresh clots per rectum) is usually a sign of a lower gastrointestinal (LGI) source (defined as distal to the ligament of Treitz).</p><p>The initial approach to a child with suspected UGI bleeding is discussed in this topic review. The approach to LGI bleeding in children, or to UGI bleeding in adults, is reviewed separately. (See  <a class="medical medical_review" href="/d/html/5904.html" rel="external">"Lower gastrointestinal bleeding in children: Causes and diagnostic approach"</a> and  <a class="medical medical_review" href="/d/html/2548.html" rel="external">"Approach to acute upper gastrointestinal bleeding in adults"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>The incidence of UGI bleeding is not well established in children. As much as 20 percent of all episodes of gastrointestinal (GI) bleeding in children come from a UGI source [<a href="#rid1">1</a>]. A population-based study from France estimated that UGI bleeding occurred in 1 to 2 per 10,000 children per year (77 percent of whom required hospitalization) and that exposure to nonsteroidal antiinflammatory drugs (NSAIDs) played a role in 36 percent of these cases [<a href="#rid2">2</a>].</p><p>The most detailed studies have been in the critical care setting [<a href="#rid3">3-5</a>]. In one of the largest prospective studies, UGI bleeding (defined for this study as hematemesis or any amount of blood from the nasogastric tube) was observed in 63 of 984 (6.4 percent) pediatric intensive care unit admissions [<a href="#rid4">4</a>]. Independent risk factors for bleeding included a high Pediatric Risk Mortality score, coagulopathy, pneumonia, and multiple trauma. Higher rates of bleeding (up to 25 percent) were observed in two other series of critically ill pediatric patients who were not receiving prophylactic therapy to prevent UGI bleeding [<a href="#rid3">3,5</a>].</p><p class="headingAnchor" id="H3"><span class="h1">ETIOLOGY</span><span class="headingEndMark"> — </span>The most common causes of UGI bleeding in children vary depending upon age and the geographic setting. In Western countries, the most common causes are gastric and duodenal ulcers, esophagitis, gastritis, and varices [<a href="#rid6">6-8</a>]. In India and some other parts of the world, variceal bleeding predominates [<a href="#rid9">9,10</a>]. These observations may reflect regional differences in indications for endoscopy, in addition to differences in predisposing conditions. Conditions associated with structural abnormalities of blood vessels (such as hereditary hemorrhagic telangiectasia and Ehlers-Danlos syndrome) and congenital or acquired coagulopathies can produce bleeding at any time of life [<a href="#rid11">11</a>].</p><p class="headingAnchor" id="H4"><span class="h2">Neonates</span><span class="headingEndMark"> — </span>UGI bleeding is rare in the first month of life but may occur for a variety of reasons  (<a class="graphic graphic_table graphicRef68243" href="/d/graphic/68243.html" rel="external">table 1</a>) [<a href="#rid12">12-25</a>]. Important considerations include:</p><p class="bulletIndent1"><span class="glyph">●</span>True UGI bleeding in a neonate must be distinguished from swallowed maternal blood. (See <a class="local">'Differential diagnosis'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vitamin K-deficient bleeding</strong> – Vitamin K deficient bleeding (also known as hemorrhagic disease of the newborn) should be considered in neonates who were not given vitamin K prophylaxis at birth. (See  <a class="medical medical_review" href="/d/html/2624.html" rel="external">"Overview of vitamin K", section on 'Vitamin K-deficient bleeding in newborns and young infants'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Stress gastritis or ulcers</strong> – These are associated with critical illness but also may occur spontaneously even in the first few days of life [<a href="#rid16">16</a>], in rare instances.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Congenital anomalies</strong> – Anomalies such as intestinal duplications or vascular anomalies may present with gastrointestinal (GI) hemorrhage [<a href="#rid19">19,23,26,27</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Coagulopathy</strong> – Coagulopathy in a neonate may also be caused by infection, liver failure, or a congenital coagulation factor deficiency. Several types of coagulopathies can present during the newborn period. Most present with other bleeding symptoms, such as a large cephalohematoma after vaginal delivery, oozing from the umbilical stump, prolonged bleeding after circumcision or blood sampling, or intracranial hemorrhage in a term infant [<a href="#rid28">28</a>]. Occasionally, these coagulopathies come to medical attention because of GI bleeding, but this rarely occurs during the neonatal period.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Food protein intolerance</strong> – Food protein intolerance, (usually involving cow's milk) may present with UGI bleeding, although lower gastrointestinal (LGI) bleeding is much more common. Care must be taken to exclude other causes of UGI bleeding, as outlined below, because UGI bleeding or passage of blood per rectum alone is not diagnostic of milk protein intolerance. (See  <a class="medical medical_review" href="/d/html/5897.html" rel="external">"Food protein-induced allergic proctocolitis of infancy"</a>.)</p><p></p><p class="headingAnchor" id="H5"><span class="h2">Infants, children, and adolescents</span><span class="headingEndMark"> — </span>The spectrum of causes of UGI bleeding in children is similar to that in adults, although some risk factors vary with age  (<a class="graphic graphic_table graphicRef68243" href="/d/graphic/68243.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef71768" href="/d/graphic/71768.html" rel="external">table 2</a>) [<a href="#rid12">12,25</a>]. Particular considerations include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mallory-Weiss syndrome</strong> – Mallory-Weiss syndrome is characterized by longitudinal mucosal lacerations in the distal esophagus, usually developing after forceful retching. The bleeding is usually small and self-limited but occasionally is severe. (See  <a class="medical medical_review" href="/d/html/2272.html" rel="external">"Mallory-Weiss syndrome"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Esophageal or GI foreign body</strong> – A foreign body can cause GI bleeding if it is sharp, caustic, and/or lodged in the esophagus. Clinical clues to this possibility include a history of a choking episode, even if it was transient or occurred days or even weeks before the bleeding episode. Rarely, ingestion of a button battery has led to severe UGI hemorrhage due to aortoesophageal fistula, which can be fatal [<a href="#rid29">29</a>]. (See  <a class="medical medical_review" href="/d/html/5888.html" rel="external">"Foreign bodies of the esophagus and gastrointestinal tract in children"</a> and  <a class="medical medical_review" href="/d/html/6497.html" rel="external">"Button and cylindrical battery ingestion: Clinical features, diagnosis, and initial management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Esophagitis</strong> – Esophagitis in this age group usually is caused by gastroesophageal reflux disease or eosinophilic esophagitis and occasionally by caustic ingestion. Peptic esophagitis also may develop after recurrent vomiting from other causes. (See  <a class="medical medical_review" href="/d/html/5892.html" rel="external">"Clinical manifestations and diagnosis of gastroesophageal reflux disease in children and adolescents"</a> and  <a class="medical medical_review" href="/d/html/5862.html" rel="external">"Caustic esophageal injury in children"</a> and  <a class="medical medical_review" href="/d/html/2243.html" rel="external">"Clinical manifestations and diagnosis of eosinophilic esophagitis (EoE)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Peptic ulcers and gastritis</strong> – Gastritis and ulcers occasionally occur in all age groups, typically in the setting of critical illness or use of nonsteroidal antiinflammatory drugs (NSAIDs). Young children are particularly susceptible to developing UGI bleeding after NSAID use [<a href="#rid2">2</a>]. Binge drinking of alcohol is an important cause of gastritis in adolescents. Gastritis or peptic ulcers also may be related to <em>Helicobacter</em> <em>pylori</em> infection or, occasionally, to a viral infection including cytomegalovirus [<a href="#rid25">25</a>]. In these disorders, epigastric discomfort and/or vomiting typically precede the hematemesis, which usually is low grade. (See  <a class="medical medical_review" href="/d/html/6454.html" rel="external">"Causes of acute abdominal pain in children and adolescents", section on 'Peptic ulcer disease'</a> and  <a class="medical medical_review" href="/d/html/14409.html" rel="external">"<i>Helicobacter</i> <i>pylori</i>: Diagnosis and management in the pediatric patient"</a> and  <a class="medical medical_review" href="/d/html/111.html" rel="external">"Chronic abdominal pain in children and adolescents: Approach to the evaluation"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pill esophagitis</strong> – Pill esophagitis is caused by direct injury to the esophageal mucosa from prolonged contact with certain drugs, including tetracyclines (<a class="drug drug_pediatric" data-topicid="13255" href="/d/drug information/13255.html" rel="external">doxycycline</a> and <a class="drug drug_pediatric" data-topicid="12915" href="/d/drug information/12915.html" rel="external">minocycline</a>) that are commonly used for treatment of acne, or by NSAIDs including <a class="drug drug_pediatric" data-topicid="12829" href="/d/drug information/12829.html" rel="external">aspirin</a>, or with the use of bisphosphonates. The condition presents with pain with swallowing (odynophagia) and may progress to hematemesis. Similar symptoms may be caused by infectious esophagitis (due to <em>Candida</em>, cytomegalovirus, or herpes simplex). (See  <a class="medical medical_review" href="/d/html/2255.html" rel="external">"Pill esophagitis"</a> and  <a class="medical medical_review" href="/d/html/5892.html" rel="external">"Clinical manifestations and diagnosis of gastroesophageal reflux disease in children and adolescents", section on 'Dysphagia or odynophagia'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Esophageal varices</strong> – Variceal bleeding is the most common cause of <strong>severe</strong> acute UGI bleeding in children. Esophageal varices are caused by portal vein hypertension. Clues to portal hypertension include splenomegaly and/or a history of thrombocytopenia, even in a patient without a history of liver disease. Causes of portal hypertension include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cirrhosis due to chronic liver disease (eg, cystic fibrosis-related liver disease, biliary atresia, or intestinal failure-associated liver disease). (See  <a class="medical medical_review" href="/d/html/99126.html" rel="external">"Cystic fibrosis: Hepatobiliary disease"</a> and  <a class="medical medical_review" href="/d/html/14369.html" rel="external">"Biliary atresia"</a> and  <a class="medical medical_review" href="/d/html/5948.html" rel="external">"Intestinal failure-associated liver disease in infants"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Portal vein thrombosis is most commonly associated with a history of umbilical vein catheterization or sepsis during the neonatal period. In some patients, the disorder first presents as an acute variceal bleed, which can be severe [<a href="#rid30">30</a>]. (See  <a class="medical medical_review" href="/d/html/88014.html" rel="external">"Chronic portal vein thrombosis in adults: Clinical manifestations, diagnosis, and management"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hepatic vein obstruction (Budd-Chiari syndrome). (See  <a class="medical medical_review" href="/d/html/3562.html" rel="external">"Budd-Chiari syndrome: Epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Arterial bleeding</strong> – Rarely, severe acute UGI bleeding is from an artery, either from an overlying peptic ulcer or a Dieulafoy lesion [<a href="#rid31">31,32</a>]. (See  <a class="medical medical_review" href="/d/html/2644.html" rel="external">"Causes of upper gastrointestinal bleeding in adults", section on 'Vascular lesions'</a>.)</p><p></p><p>Unusual causes of UGI bleeding have been described in case reports, including hemangiomas [<a href="#rid23">23,33</a>], aortoesophageal fistulas [<a href="#rid29">29,34</a>], hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome) [<a href="#rid35">35</a>], Kasabach-Merritt syndrome [<a href="#rid36">36</a>], duplication cysts [<a href="#rid26">26,27,37</a>], parasites [<a href="#rid38">38</a>], vasculitis [<a href="#rid39">39</a>], gastric polyps, annular pancreas [<a href="#rid40">40</a>], antral or duodenal web [<a href="#rid41">41,42</a>], and systemic mastocytosis [<a href="#rid12">12,25,43</a>].</p><p class="headingAnchor" id="H7"><span class="h2">Differential diagnosis</span><span class="headingEndMark"> — </span>The differential diagnosis of UGI bleeding includes vomited blood originating from structures or organs other than the GI tract and ingested blood or blood-like substances:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Swallowed maternal blood</strong> – Neonates and infants may swallow maternal blood during delivery or while nursing, and this can mimic UGI bleeding [<a href="#rid44">44</a>]. One method with which to distinguish maternal blood is the Apt-Downey test. Fetal hemoglobin is resistant to denaturation in an alkaline solution and remains red or pink, while adult hemoglobin discolors to a brownish yellow. The Apt-Downey test is valid for only the first few months of life because the percentage of fetal hemoglobin decreases sharply during this period. (See  <a class="medical medical_review" href="/d/html/5904.html" rel="external">"Lower gastrointestinal bleeding in children: Causes and diagnostic approach", section on 'Swallowed maternal blood'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epistaxis</strong> – Swallowed blood from the patient's nasopharynx or respiratory tract may be very difficult to distinguish from UGI bleeding. This source should be considered in a child with a history of recent or recurrent epistaxis. To evaluate this possibility, the physical examination should include inspection of the nares for evidence of venous injury of the anterior medial septums. Some patients may require endoscopic evaluation to adequately assess for lesions in the nasopharynx, larynx, or respiratory tract. (See  <a class="medical medical_review" href="/d/html/6451.html" rel="external">"Evaluation of epistaxis in children"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Substances that resemble blood</strong> – Red food colorings and dyes (eg, red-colored drinks or liquid medications) also may be confused with blood, particularly after vomiting. While this can frequently be suspected from this history, bedside tests for occult blood also can be helpful. These tests rely on color changes to detect the presence of hemoglobin. However, some of the commercial tests (such as Hemoccult) may produce false-negative results in the presence of acid. It is preferable to use a kit designed specifically to detect blood in gastric secretions (eg, Gastroccult), which incorporate additional alkali to neutralize the gastric acid present in emesis [<a href="#rid45">45</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Medical child abuse</strong> – Factitious illness (Munchausen syndrome by proxy), caused by surreptitious administration of blood or blood-like substance to simulate UGI bleeding, should be considered in patients with unexplained GI bleeding [<a href="#rid46">46</a>]. The patient or siblings may have a history of frequent recurrent illnesses without a clear etiology. (See  <a class="medical medical_review" href="/d/html/6608.html" rel="external">"Medical child abuse (Munchausen syndrome by proxy)"</a>.)</p><p></p><p class="headingAnchor" id="H368708916"><span class="h1">CLINICAL PRESENTATION</span><span class="headingEndMark"> — </span>UGI bleeding typically presents with hematemesis (vomiting of blood or coffee ground-like material) and/or melena (black, tarry stools).</p><p class="bulletIndent1"><span class="glyph">●</span>Hematemesis – Bright red blood usually indicates brisk or very fresh bleeding. Coffee ground-like material generally indicates a slower rate of bleeding because this appearance is caused by the effect of gastric acid on blood. This effect can be altered with acid suppression therapy.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Stool – UGI bleeding tends to be associated with melena (dark red or black and sticky stools), while lower gastrointestinal (LGI) bleeding tends to be associated with hematochezia (bright red in color). However, these distinctions in stool color are not absolute, because melena can be seen with proximal LGI bleeding and hematochezia can be seen with massive UGI bleeding. Because of short intestinal transit time, neonates and infants with UGI bleeding are more likely than adults to present with hematochezia. (See  <a class="medical medical_review" href="/d/html/5904.html" rel="external">"Lower gastrointestinal bleeding in children: Causes and diagnostic approach", section on 'Diagnostic approach'</a>.)</p><p></p><p class="headingAnchor" id="H8"><span class="h1">CLINICAL ASSESSMENT</span><span class="headingEndMark"> — </span>The initial evaluation of the patient with UGI bleeding should always start with an assessment of hemodynamic stability and resuscitation, if indicated. Rapid assessment and early resuscitation are particularly important in children. Diagnostic studies follow, with the goal of diagnosing the cause of the bleed. Endoscopy usually is indicated if the bleeding is brisk or unexplained after a thorough history and physical examination, or if there are associated signs of shock. Brisk bleeding is suggested by repeated episodes of grossly bloody emesis or large volumes of blood aspirated through a nasogastric tube, or a persistent drop in hemoglobin. In some cases, the source of the bleeding can be treated through the endoscopic procedure. Endoscopic evaluation and treatment should generally be performed after the patient is stabilized and within 24 to 48 hours of presentation of the gastrointestinal (GI) bleed.</p><p class="headingAnchor" id="H13582162"><span class="h2">Initial assessment and resuscitation</span><span class="headingEndMark"> — </span>Vital signs, including the heart rate, blood pressure, presence of orthostatic changes, and capillary refill, are used to assess and monitor the hemodynamic state of the patient. Patients with hemodynamic instability (shock, orthostatic hypotension) should be admitted to an intensive care unit for resuscitation and close observation. Such patients should be stabilized prior to endoscopy. Both a gastroenterologist and a surgeon should be notified promptly of all patients with severe acute UGI bleeding.</p><p>Clinical features suggesting a severe UGI bleed are [<a href="#rid47">47,48</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Melena or hematochezia</p><p class="bulletIndent1"><span class="glyph">●</span>Heart rate &gt;20 beats per minute above the mean heart rate for age</p><p class="bulletIndent1"><span class="glyph">●</span>Prolonged capillary refill time</p><p class="bulletIndent1"><span class="glyph">●</span>Decrease in hemoglobin of more than 2 g/dL</p><p class="bulletIndent1"><span class="glyph">●</span>Need for fluid bolus</p><p class="bulletIndent1"><span class="glyph">●</span>Need for blood transfusion (given if hemoglobin &lt;8 g/dL)</p><p></p><p>The principles involved in resuscitation of children with hemorrhagic shock including UGI bleeding are discussed separately. (See  <a class="medical medical_review" href="/d/html/6389.html" rel="external">"Hypovolemic shock in children in resource-abundant settings: Initial evaluation and management", section on 'Fluid resuscitation'</a>.)</p><p>Obtaining intravenous (IV) access can be difficult, especially in severely volume-depleted patients. Intraosseous fluids or central venous access may be required in this setting. (See  <a class="medical medical_review" href="/d/html/6321.html" rel="external">"Intraosseous infusion"</a>.)</p><p class="headingAnchor" id="H9"><span class="h2">History</span><span class="headingEndMark"> — </span>The clinical history should include information concerning the time course of the bleeding episode, estimated blood loss, and any associated symptoms  (<a class="graphic graphic_table graphicRef101153" href="/d/graphic/101153.html" rel="external">table 3</a>). The presence of hematemesis, melena, or hematochezia should be documented; these characteristics provide clues about the source and rate of bleeding (see <a class="local">'Clinical presentation'</a> above). Particular attention should be given to GI symptoms including dyspepsia, heartburn, abdominal pain, dysphagia, and weight loss. In infants, these features may be reflected in poor feeding and irritability.</p><p>The history should also include information about the following symptoms or signs, which may provide clues to an underlying disorder:</p><p class="bulletIndent1"><span class="glyph">●</span>Recent onset of jaundice, easy bruising, or change in stool color, which may suggest underlying liver disease</p><p class="bulletIndent1"><span class="glyph">●</span>Recent or recurrent epistaxis, to investigate the possibility of a nasopharyngeal source of bleeding</p><p class="bulletIndent1"><span class="glyph">●</span>History of easy bruising or bleeding, which suggests a disorder of coagulation, platelet dysfunction, or thrombocytopenia</p><p class="bulletIndent1"><span class="glyph">●</span>Personal or family history of liver, kidney, or heart disease, or coagulation disorders</p><p></p><p>A drug history is important to assess potential contributions from medications that may induce ulceration (such as nonsteroidal antiinflammatory drugs [NSAIDs] and corticosteroids); even short-term use of <a class="drug drug_pediatric" data-topicid="13371" href="/d/drug information/13371.html" rel="external">ibuprofen</a> can cause gastric ulcers and hematemesis [<a href="#rid49">49</a>]. Tetracyclines, which are commonly used to treat acne, may cause a pill esophagitis (see  <a class="medical medical_review" href="/d/html/2255.html" rel="external">"Pill esophagitis"</a>). Some medications, such as NSAIDs, also affect coagulation and can exacerbate bleeding from another cause. Alcohol ingestion (in particular, binge drinking) and tobacco use can contribute to peptic ulcer disease, and large intakes of caffeine (eg, from coffee or caffeinated sodas) can promote acid secretion and dyspepsia. (See  <a class="medical medical_review" href="/d/html/22.html" rel="external">"Peptic ulcer disease: Epidemiology, etiology, and pathogenesis"</a>.)</p><p>In addition, it is important to know if the patient has been taking drugs or has a cardiac condition that affects homeostatic responses (such as beta-adrenergic antagonists) because these may mask tachycardia associated with life-threatening hypovolemia and shock.</p><p class="headingAnchor" id="H13582270"><span class="h2">Physical examination</span><span class="headingEndMark"> — </span>The rapid assessment of hemodynamic status is described above. The remainder of the physical examination should include the following elements, which suggest possible sources for the bleeding  (<a class="graphic graphic_table graphicRef101154" href="/d/graphic/101154.html" rel="external">table 4</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Examination of the skin and mucus membranes for bruising, petechiae, or mucosal bleeding. Depending on the presentation and pattern, these findings may suggest a bleeding disorder (eg, immune thrombocytopenia [ITP]), trauma, or liver disease.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Examination of the skin for cutaneous signs of generalized vascular malformations/disorders. The presence of cutaneous hemangiomas (especially five or more) suggests the possibility of GI hemangiomatosis. However, up to 50 percent of infants with visceral hemangiomas do not have cutaneous hemangiomas [<a href="#rid33">33</a>]. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome) is characterized by mucocutaneous telangiectasia  (<a class="graphic graphic_picture graphicRef52483" href="/d/graphic/52483.html" rel="external">picture 1</a>) and commonly presents with recurrent epistaxis and/or GI bleeding. (See  <a class="medical medical_review" href="/d/html/5794.html" rel="external">"Infantile hemangiomas: Epidemiology, pathogenesis, clinical features, and complications"</a> and  <a class="medical medical_review" href="/d/html/1345.html" rel="external">"Clinical manifestations and diagnosis of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Abdominal examination for evidence of portal hypertension, such as splenomegaly or prominent cutaneous abdominal and hemorrhoidal vessels and a protruding abdomen. Portal hypertension often leads to esophageal varices, which may hemorrhage.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Inspection of the nasopharynx for evidence of disrupted mucosa or inflamed tonsils suggesting swallowed blood, and inspection of the anterior nares for evidence of venous injury of the anterior medial septum. If present, these findings suggest the possibility of a nasopharyngeal rather than UGI bleed. (See <a class="local">'Differential diagnosis'</a> above and  <a class="medical medical_review" href="/d/html/6451.html" rel="external">"Evaluation of epistaxis in children"</a>.)</p><p></p><p>In patients presenting with unexplained GI bleeding that is clinically significant, nasogastric or orogastric tube lavage is often used to confirm the diagnosis and to determine if the bleeding is ongoing. (See <a class="local">'Nasogastric tube'</a> below.)</p><p class="headingAnchor" id="H13582277"><span class="h2">Laboratory evaluation</span><span class="headingEndMark"> — </span>The laboratory assessment depends on the clinical scenario and magnitude of the blood loss. In most cases, it should include a complete blood count, coagulation studies, tests evaluating liver function, blood urea nitrogen (BUN), and serum creatinine. For patients with epigastric abdominal pain, pancreatitis also should be ruled out with screening amylase and lipase; pancreatitis occasionally is associated with gastritis, duodenitis, and peptic ulcer disease. For patients with clinically significant bleeding or known varices, a specimen should be drawn to type and cross-match blood in case transfusion is required. Less extensive laboratory evaluation may be appropriate for patients with small amounts of blood in the vomitus and a likely explanation.</p><p>The BUN result can be helpful for confirming the source of bleeding. An increase in BUN in the absence of renal disease is consistent with a UGI (rather than a lower gastrointestinal [LGI]) source of blood loss because blood in the proximal GI tract has relatively more time to be absorbed, leading to an increase in the BUN. However, a normal or low BUN does not rule out a UGI bleed.</p><p class="headingAnchor" id="H368706649"><span class="h2">Imaging</span><span class="headingEndMark"> — </span>Imaging tests can be helpful in specific clinical settings:</p><p class="bulletIndent1"><span class="glyph">●</span>Plain radiographs may be helpful to identify a foreign body if this is suspected by the clinical history. They are also helpful to evaluate for bowel obstruction or perforation in patients with significant abdominal pain, distension, or tenderness.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Abdominal ultrasound can be used to evaluate splenomegaly and portal hypertension and should be performed in patients with severe acute UGI bleed suggestive of variceal bleeding, known or suspected liver disease, or those with signs of portal hypertension on examination (eg, splenomegaly, prominent abdominal wall vessels).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>UGI <a class="drug drug_pediatric" data-topicid="118048" href="/d/drug information/118048.html" rel="external">barium</a> studies should <strong>not</strong> be performed in the setting of UGI bleeding, because the contrast will interfere with subsequent endoscopy, angiography, or surgery.</p><p></p><p class="headingAnchor" id="H1658666060"><span class="h2">Endoscopy</span><span class="headingEndMark"> — </span>Endoscopy is often required in patients with UGI bleeding for both diagnostic and therapeutic purposes, as discussed below. (See <a class="local">'Endoscopy'</a> below.)</p><p class="headingAnchor" id="H1658666147"><span class="h2">Other diagnostic tests</span><span class="headingEndMark"> — </span>Rarely, angiography or radionuclide imaging may be needed to identify a source of bleeding.</p><p class="bulletIndent1"><span class="glyph">●</span>Angiography may be useful in patients with rapid bleeding in whom endoscopy is unsuccessful in finding a source. For diagnostic purposes, magnetic resonance angiography (MRA) or computed tomographic angiography (CTA) may be used [<a href="#rid50">50,51</a>]; the preferred method may be specific to a particular institution. For therapeutic purposes, conventional contrast angiography with embolization may be useful in treating some patients with vascular anomalies, hemobilia, or some ulcers that are not amenable to other types of treatment [<a href="#rid52">52</a>]. (See  <a class="medical medical_review" href="/d/html/2540.html" rel="external">"Angiographic control of nonvariceal gastrointestinal bleeding in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Radionuclide imaging (a tagged red blood cell scan) also can be used to detect an obscure bleeding source for patients with very brisk bleeding. However, this is rarely helpful in patients with UGI bleeding because endoscopy is far more sensitive for detecting bleeding above the ligament of Treitz. (See  <a class="medical medical_review" href="/d/html/2625.html" rel="external">"Evaluation of suspected small bowel bleeding (formerly obscure gastrointestinal bleeding)"</a>.)</p><p></p><p class="headingAnchor" id="H368706575"><span class="h1">MANAGEMENT</span><span class="headingEndMark"> — </span>For hemodynamically stable patients with small amounts of blood in the vomitus with a likely explanation (eg, Mallory-Weiss tear), supportive care with observation generally is sufficient, usually with acid suppression to treat any peptic component and reduce the risk for rebleeding. For patients with larger amounts of blood in vomitus or hemodynamic instability, the following interventions may be used:</p><p class="headingAnchor" id="H11"><span class="h2">Nasogastric tube</span><span class="headingEndMark"> — </span>In patients presenting with unexplained gastrointestinal (GI) bleeding that is clinically significant (eg, more than a teaspoon estimated blood loss), nasogastric or orogastric tube lavage is often used to confirm the diagnosis and to determine if the bleeding is ongoing. This approach is particularly helpful if the bleeding is suspected to be a vascular bleed (eg, variceal). The lavage will also remove particulate matter, fresh blood, and clots to facilitate endoscopy and decrease the risk of aspiration. The lavage may be performed with either water or normal <a class="drug drug_pediatric" data-topicid="12796" href="/d/drug information/12796.html" rel="external">saline</a>, at room temperature. Ice water lavage is <strong>not</strong> recommended; this older practice does not slow bleeding [<a href="#rid53">53</a>] and may induce iatrogenic hypothermia, particularly in infants and small children.</p><p>If the lavage returns fresh blood or blood with the appearance of coffee grounds, this helps to confirm a UGI (or nasopharyngeal) source of bleeding. However, lavage may not be positive if the bleeding has ceased or arises beyond a closed pylorus. The presence of bilious fluid suggests that the pylorus is open and if lavage is negative, that there is no active UGI bleeding.</p><p class="headingAnchor" id="H13582296"><span class="h2">Pharmacologic options</span><span class="headingEndMark"> — </span>Acid suppression usually is appropriate for children with clinically significant UGI bleeding to treat or prevent any peptic component of the underlying disorder. Vasoactive agents may be helpful for selected cases of vascular bleeding (eg, from esophageal varices). The most commonly used drugs and doses are summarized in the table  (<a class="graphic graphic_table graphicRef101156" href="/d/graphic/101156.html" rel="external">table 5</a>).</p><p class="headingAnchor" id="H12"><span class="h3">Acid suppression</span><span class="headingEndMark"> — </span>We suggest acid suppression for children with UGI bleeding. For hemodynamically unstable children or those with large-volume bleeding, we suggest an intravenous (IV) preparation of a proton pump inhibitor (PPI; <a class="drug drug_pediatric" data-topicid="13281" href="/d/drug information/13281.html" rel="external">esomeprazole</a> or <a class="drug drug_pediatric" data-topicid="12677" href="/d/drug information/12677.html" rel="external">pantoprazole</a>) or histamine 2 receptor antagonist (<a class="drug drug_pediatric" data-topicid="13295" href="/d/drug information/13295.html" rel="external">famotidine</a>). For hemodynamically stable children with mild bleeding, we suggest oral administration of a PPI such as <a class="drug drug_pediatric" data-topicid="12658" href="/d/drug information/12658.html" rel="external">omeprazole</a> or esomeprazole.</p><p>This suggestion for acid suppression is primarily based on studies in adults, which have examined the effect of acid suppression given before or after endoscopy (with or without therapeutic intervention). In the setting of active UGI bleeding due to peptic ulcers, high-dose antisecretory therapy with an IV infusion of PPI significantly reduced the rate of rebleeding compared with standard treatment in patients with bleeding ulcers. Oral and IV PPI therapy also decrease the hospital stay, rebleeding rate, and the need for blood transfusion in adult patients with high-risk ulcers treated with endoscopic therapy. (See  <a class="medical medical_review" href="/d/html/2548.html" rel="external">"Approach to acute upper gastrointestinal bleeding in adults", section on 'Acid suppression'</a>.)</p><p class="headingAnchor" id="H13"><span class="h3">Somatostatin and octreotide</span><span class="headingEndMark"> — </span><a class="drug drug_pediatric" data-topicid="12655" href="/d/drug information/12655.html" rel="external">Octreotide</a> (an analog of somatostatin) may help in reducing or temporizing GI bleeding in selected cases of variceal bleeding that are difficult to control as adjunctive therapy to help control bleeding before endoscopy or when endoscopy is unsuccessful, contraindicated, or unavailable [<a href="#rid54">54-56</a>]. Octreotide reduces portal venous inflow and intravariceal pressure; these medications reduce the risk of rebleeding in adult patients with variceal hemorrhage. In addition, these medications may reduce the risk of bleeding due to nonvariceal causes [<a href="#rid57">57</a>]. (See  <a class="medical medical_review" href="/d/html/2573.html" rel="external">"Overview of the treatment of bleeding peptic ulcers"</a> and  <a class="medical medical_review" href="/d/html/1260.html" rel="external">"Methods to achieve hemostasis in patients with acute variceal hemorrhage"</a>.)</p><p>Guidelines for the use of <a class="drug drug_pediatric" data-topicid="12655" href="/d/drug information/12655.html" rel="external">octreotide</a> in the pediatric age group have not been developed, but octreotide is commonly administered as an initial bolus of 1 to 2 microgram/kg body weight (maximum 100 micrograms), followed by 1 to 2 microgram/kg/hour as a continuous IV infusion [<a href="#rid56">56</a>]. The infusion rate is titrated to the response. The optimal duration of therapy is unclear. Adverse effects include bradycardia and hyperglycemia. If bleeding stops, octreotide doses are typically tapered gradually over approximately 24 hours. Discovering and treating the cause of the GI bleed should remain the principal goal.</p><p>Experience with <a class="drug drug_pediatric" data-topicid="12655" href="/d/drug information/12655.html" rel="external">octreotide</a> in children is limited [<a href="#rid54">54,55,58</a>]. Some providers prefer octreotide over <a class="drug drug_pediatric" data-topicid="12876" href="/d/drug information/12876.html" rel="external">vasopressin</a> for the treatment of acute variceal hemorrhage because it appears to have better efficacy and fewer side effects, but data on either of these drugs in children are limited. (See  <a class="medical medical_review" href="/d/html/1260.html" rel="external">"Methods to achieve hemostasis in patients with acute variceal hemorrhage", section on 'Pharmacologic therapy'</a>.)</p><p class="headingAnchor" id="H14"><span class="h2">Endoscopy</span><span class="headingEndMark"> — </span>Guidelines recommend that endoscopy be performed within 24 to 48 hours for infants and children presenting with UGI bleeding that is acute and severe, particularly if transfusions are required [<a href="#rid59">59</a>]. Earlier endoscopy may be needed if bleeding cannot be controlled. Hemodynamically unstable patients should be stabilized prior to endoscopy, including transfusion and correction of coagulopathy if present. Endoscopy is also appropriate in children with low-grade bleeding that is unexplained and persistent or recurrent [<a href="#rid12">12</a>].</p><p>Upper endoscopy permits identification of the bleeding source, allows for risk stratification regarding the likelihood of continued bleeding, and permits therapeutic intervention. Multiple reports have attested to the safety of upper endoscopy in children [<a href="#rid7">7,8,60-62</a>]. The techniques involved in performing an endoscopy and therapeutic intervention are similar in children and adults and include thermal coagulation or clips for bleeding ulcers and ligation (banding) or sclerotherapy for variceal bleeding. (See  <a class="medical medical_review" href="/d/html/2573.html" rel="external">"Overview of the treatment of bleeding peptic ulcers"</a> and  <a class="medical medical_review" href="/d/html/1260.html" rel="external">"Methods to achieve hemostasis in patients with acute variceal hemorrhage"</a>.)</p><p>However, there are several considerations pertinent to children:</p><p class="bulletIndent1"><span class="glyph">●</span>Children often require deep sedation or general anesthesia for upper endoscopy. For patients with active or severe bleeding, or if endoscopic therapy is anticipated, general anesthesia with endotracheal intubation is appropriate. This approach optimizes the examination and minimizes the risk of aspiration of the blood. Moreover, in some series, use of general anesthesia, administered by a dedicated anesthesiologist, was associated with a lower rate of complications than use of deep sedation [<a href="#rid63">63,64</a>]. Children undergoing endoscopy for a GI bleed should be carefully monitored during the procedure; sedation in these cases should be guided by a clinician experienced in anesthesiology or intensive care.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Smaller-caliber endoscopes limit the size of catheters that can be passed through the working channel.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Band ligation of esophageal varices is often possible, but use of this technique in small children is limited by the small diameter of the esophagus [<a href="#rid65">65-68</a>]. In small children, an overtube should probably not be used [<a href="#rid12">12</a>]. (See  <a class="medical medical_review" href="/d/html/1264.html" rel="external">"Endoscopic variceal ligation"</a>.)</p><p></p><p>Surgery or contrast angiography with embolization is reserved for the uncommon patients in whom endoscopy fails to control bleeding or in whom an anatomic abnormality exists that requires surgery, and if the patient cannot be fully stabilized despite resuscitative measures.</p><p class="headingAnchor" id="H1244916171"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/114135.html" rel="external">"Society guideline links: Gastrointestinal bleeding in children"</a> and  <a class="medical medical_society_guidelines" href="/d/html/112393.html" rel="external">"Society guideline links: Hemophilia A and B"</a> and  <a class="medical medical_society_guidelines" href="/d/html/119323.html" rel="external">"Society guideline links: von Willebrand disease"</a> and  <a class="medical medical_society_guidelines" href="/d/html/119328.html" rel="external">"Society guideline links: Acquired bleeding disorders"</a> and  <a class="medical medical_society_guidelines" href="/d/html/119326.html" rel="external">"Society guideline links: Rare inherited bleeding disorders"</a> and  <a class="medical medical_society_guidelines" href="/d/html/117855.html" rel="external">"Society guideline links: Peptic ulcer disease"</a>.)</p><p class="headingAnchor" id="H16"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical presentation</strong> – Upper gastrointestinal (UGI) bleeding can present with hematemesis (vomiting of blood or coffee ground-like material) and/or melena (black, tarry stools). The appearance of the stool is not a reliable indicator of the source of the bleeding. Although melena suggests UGI bleeding, it may also occur in patients with a proximal lower gastrointestinal (LGI) source. Conversely, patients with brisk UGI bleeding and rapid intestinal transit time may present with hematochezia, particularly if they are infants or toddlers. (See <a class="local">'Clinical presentation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Causes</strong> – The most common causes of UGI bleeding in children vary depending upon age and the geographic setting. In Western countries, the most common causes are Mallory-Weiss tears, gastric and duodenal ulcers, esophagitis, gastritis, and varices  (<a class="graphic graphic_table graphicRef68243" href="/d/graphic/68243.html" rel="external">table 1</a>). Very rapid UGI bleeding is characteristic of variceal hemorrhage and may be the presenting symptom of portal hypertension. (See <a class="local">'Etiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical assessment</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Stabilization</strong> – The initial evaluation of the patient with UGI bleeding involves an assessment of hemodynamic stability and resuscitation, if necessary. (See <a class="local">'Initial assessment and resuscitation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>History and physical examination</strong> – The pattern of vomiting, associated symptoms, and underlying diseases help to identify the likely cause of the bleeding, as summarized in the table  (<a class="graphic graphic_table graphicRef101153" href="/d/graphic/101153.html" rel="external">table 3</a>). On the physical examination, important clues include bruises, petechiae, or mucosal bleeding (suggesting a bleeding disorder or trauma), and splenomegaly (suggesting portal hypertension)  (<a class="graphic graphic_table graphicRef101154" href="/d/graphic/101154.html" rel="external">table 4</a>). Key considerations include:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>History of a choking episode, even if transient and/or days or weeks before, suggests possible foreign body ingestion.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Odynophagia (pain while swallowing) and use of certain medications including tetracyclines suggest possible pill esophagitis.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>History of epistaxis and/or signs of blood in the nose and oropharynx suggest a nasopharyngeal bleeding source. Swallowed blood from the nasopharynx may present with hematemesis or melena and may be difficult to distinguish from UGI bleeding. (See <a class="local">'Differential diagnosis'</a> above and <a class="local">'Physical examination'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Lavage</strong> – Nasogastric or orogastric lavage may be performed in patients with clinically significant UGI bleeding to confirm the location and to remove fresh blood or particulate matter from the stomach to facilitate endoscopy. Lavage using ice water is <strong>not</strong> recommended, and frequent lavage can lead to electrolyte imbalances. (See <a class="local">'Nasogastric tube'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Acid suppression</strong> – We suggest acid suppression for children with UGI bleeding (<a class="grade" href="https://medilib.ir/uptodate/show/grade_5" rel="external">Grade 2B</a>). For hemodynamically stable children with mild bleeding, we suggest oral administration of a proton pump inhibitor (PPI) such as <a class="drug drug_pediatric" data-topicid="12658" href="/d/drug information/12658.html" rel="external">omeprazole</a> or <a class="drug drug_pediatric" data-topicid="13281" href="/d/drug information/13281.html" rel="external">esomeprazole</a>. For hemodynamically unstable children or those with large-volume bleeding, we suggest an intravenous (IV) preparation of a PPI (esomeprazole or <a class="drug drug_pediatric" data-topicid="12677" href="/d/drug information/12677.html" rel="external">pantoprazole</a>) or histamine 2 receptor antagonist (<a class="drug drug_pediatric" data-topicid="13295" href="/d/drug information/13295.html" rel="external">famotidine</a>)  (<a class="graphic graphic_table graphicRef101156" href="/d/graphic/101156.html" rel="external">table 5</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Endoscopy</strong> – Upper endoscopy should be performed in patients with acute severe hemorrhage, or low-grade persistent or recurrent hemorrhage. Endoscopy usually permits identification of the bleeding source, allows for risk stratification regarding the likelihood of continued bleeding, and in some cases, permits therapeutic intervention. (See <a class="local">'Endoscopy'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Rodgers BM. Upper gastrointestinal hemorrhage. Pediatr Rev 1999; 20:171.</a></li><li><a class="nounderline abstract_t">Grimaldi-Bensouda L, Abenhaim L, Michaud L, et al. Clinical features and risk factors for upper gastrointestinal bleeding in children: a case-crossover study. Eur J Clin Pharmacol 2010; 66:831.</a></li><li><a class="nounderline abstract_t">Cochran EB, Phelps SJ, Tolley EA, Stidham GL. Prevalence of, and risk factors for, upper gastrointestinal tract bleeding in critically ill pediatric patients. Crit Care Med 1992; 20:1519.</a></li><li><a class="nounderline abstract_t">Lacroix J, Nadeau D, Laberge S, et al. Frequency of upper gastrointestinal bleeding in a pediatric intensive care unit. Crit Care Med 1992; 20:35.</a></li><li><a class="nounderline abstract_t">López-Herce J, Dorao P, Elola P, et al. Frequency and prophylaxis of upper gastrointestinal hemorrhage in critically ill children: a prospective study comparing the efficacy of almagate, ranitidine, and sucralfate. The Gastrointestinal Hemorrhage Study Group. Crit Care Med 1992; 20:1082.</a></li><li><a class="nounderline abstract_t">Cox K, Ament ME. Upper gastrointestinal bleeding in children and adolescents. Pediatrics 1979; 63:408.</a></li><li><a class="nounderline abstract_t">Kato S, Nakagawa H, Harada Y, et al. A clinical study of upper gastrointestinal endoscopy in Japanese children. Acta Paediatr Jpn 1991; 33:36.</a></li><li><a class="nounderline abstract_t">Zahavi I, Arnon R, Ovadia B, et al. Upper gastrointestinal endoscopy in the pediatric patient. Isr J Med Sci 1994; 30:664.</a></li><li><a class="nounderline abstract_t">Yachha SK, Khanduri A, Sharma BC, Kumar M. Gastrointestinal bleeding in children. J Gastroenterol Hepatol 1996; 11:903.</a></li><li><a class="nounderline abstract_t">Mittal SK, Kalra KK, Aggarwal V. Diagnostic upper GI endoscopy for hemetemesis in children: experience from a pediatric gastroenterology centre in north India. Indian J Pediatr 1994; 61:651.</a></li><li><a class="nounderline abstract_t">Fishman SJ, Burrows PE, Leichtner AM, Mulliken JB. Gastrointestinal manifestations of vascular anomalies in childhood: varied etiologies require multiple therapeutic modalities. J Pediatr Surg 1998; 33:1163.</a></li><li><a class="nounderline abstract_t">Fox VL. Gastrointestinal bleeding in infancy and childhood. Gastroenterol Clin North Am 2000; 29:37.</a></li><li><a class="nounderline abstract_t">Borowitz SM. Ulcerative esophagitis. A rare source of upper gastrointestinal bleeding in a neonate. Use of fiberoptic endoscopy for diagnosis. Clin Pediatr (Phila) 1989; 28:89.</a></li><li><a class="nounderline abstract_t">O'Neil EA, Chwals WJ, O'Shea MD, Turner CS. Dexamethasone treatment during ventilator dependency: possible life threatening gastrointestinal complications. Arch Dis Child 1992; 67:10.</a></li><li><a class="nounderline abstract_t">Wilcox DT, Jacobson A, Bruce J. Haemorrhage from a duodenal ulcer in a neonate. Pediatr Surg Int 1997; 12:202.</a></li><li><a class="nounderline abstract_t">Goyal A, Treem WR, Hyams JS. Severe upper gastrointestinal bleeding in healthy full-term neonates. Am J Gastroenterol 1994; 89:613.</a></li><li><a class="nounderline abstract_t">Madan A, Lavine JE, Heyman MB, Townsend SF. Acute hemorrhagic gastritis in the newborn infant. J Perinatol 1992; 12:377.</a></li><li><a class="nounderline abstract_t">Ng PC, So KW, Fok TF, et al. Fatal haemorrhagic gastritis associated with oral sulindac treatment for patent ductus arteriosus. Acta Paediatr 1996; 85:884.</a></li><li><a class="nounderline abstract_t">Peiper M, Lambrecht W, Kluth D, Hüneke B. Bleeding esophageal duplication detected in utero. Ann Thorac Surg 1995; 60:1790.</a></li><li><a class="nounderline abstract_t">Bedu A, Faure C, Sibony O, et al. Prenatal gastrointestinal bleeding caused by esophagitis and gastritis. J Pediatr 1994; 125:465.</a></li><li><a class="nounderline abstract_t">Cairo MS, Grosfeld JL, Weetman RM. Gastric teratoma: unusual cause for bleeding of the upper gastrointestinal tract in the newborn. Pediatrics 1981; 67:721.</a></li><li><a class="nounderline abstract_t">Haley T, Dimler M, Hollier P. Gastric teratoma with gastrointestinal bleeding. J Pediatr Surg 1986; 21:949.</a></li><li><a class="nounderline abstract_t">Nagaya M, Kato J, Niimi N, et al. Isolated cavernous hemangioma of the stomach in a neonate. J Pediatr Surg 1998; 33:653.</a></li><li><a class="nounderline abstract_t">Stillman AE, Hansen RC, Hallinan V, Strobel C. Diffuse neonatal hemangiomatosis with severe gastrointestinal involvement. Favorable response to steroid therapy. Clin Pediatr (Phila) 1983; 22:589.</a></li><li><a class="nounderline abstract_t">Neidich GA, Cole SR. Gastrointestinal bleeding. Pediatr Rev 2014; 35:243.</a></li><li><a class="nounderline abstract_t">Stephen TC, Bendon RW, Nagaraj HS, Sachdeva R. Antral duplication cyst: a cause of hypergastrinemia, recurrent peptic ulceration, and hemorrhage. J Pediatr Gastroenterol Nutr 1998; 26:216.</a></li><li><a class="nounderline abstract_t">Deng KH, Yuan Y, Liu W. Gastrointestinal Bleeding as Initial Presentation of Intestinal Duplication. J Pediatr Gastroenterol Nutr 2022; 74:e98.</a></li><li><a class="nounderline abstract_t">Saxonhouse MA, Manco-Johnson MJ. The evaluation and management of neonatal coagulation disorders. Semin Perinatol 2009; 33:52.</a></li><li><a class="nounderline abstract_t">Brumbaugh DE, Colson SB, Sandoval JA, et al. Management of button battery-induced hemorrhage in children. J Pediatr Gastroenterol Nutr 2011; 52:585.</a></li><li><a class="nounderline abstract_t">Ferri PM, Ferreira AR, Fagundes ED, et al. Portal vein thrombosis in children and adolescents: 20 years experience of a pediatric hepatology reference center. Arq Gastroenterol 2012; 49:69.</a></li><li><a class="nounderline abstract_t">Murray KF, Jennings RW, Fox VL. Endoscopic band ligation of a Dieulafoy lesion in the small intestine of a child. Gastrointest Endosc 1996; 44:336.</a></li><li><a class="nounderline abstract_t">Itani M, Alsaied T, Charafeddine L, Yazbeck N. Dieulafoy's lesion in children. J Pediatr Gastroenterol Nutr 2010; 51:672.</a></li><li><a class="nounderline abstract_t">Soukoulis IW, Liang MG, Fox VL, et al. Gastrointestinal Infantile Hemangioma: Presentation and Management. J Pediatr Gastroenterol Nutr 2015; 61:415.</a></li><li><a class="nounderline abstract_t">Sigalet DL, Laberge JM, DiLorenzo M, et al. Aortoesophageal fistula: congenital and acquired causes. J Pediatr Surg 1994; 29:1212.</a></li><li><a class="nounderline abstract_t">Mestre JR, Andres JM. Hereditary hemorrhagic telangiectasia causing hematemesis in an infant. J Pediatr 1982; 101:577.</a></li><li><a class="nounderline abstract_t">Bowles LJ, Kostopoulos-Farri E, Papageorgiou AN. Perinatal hemorrhage associated with the Kassabach-Merritt syndrome. Clin Pediatr (Phila) 1981; 20:428.</a></li><li><a class="nounderline abstract_t">Murty TV, Bhargava RK, Rakas FS. Gastroduodenal duplication. J Pediatr Surg 1992; 27:515.</a></li><li><a class="nounderline abstract_t">Hollander M, Tabingo R, Stankewick WR. Successful treatment of massive intestinal hemorrhage due to hookworm infection in a neonate. J Pediatr 1973; 82:332.</a></li><li><a class="nounderline abstract_t">Clark JH, Fitzgerald JF. Hemorrhagic complications of Henoch-Schönlein syndrome. J Pediatr Gastroenterol Nutr 1985; 4:311.</a></li><li><a class="nounderline abstract_t">Siew JX, Yap TL, Phua KB, et al. Annular pancreas: a rare cause of upper gastrointestinal bleeding in a child. J Pediatr Gastroenterol Nutr 2013; 57:e34.</a></li><li><a class="nounderline abstract_t">Nagpal R, Schnaufer L, Altschuler SM. Duodenal web presenting with gastrointestinal bleeding in a seven-month-old infant. J Pediatr Gastroenterol Nutr 1993; 16:90.</a></li><li><a class="nounderline abstract_t">Beluffi G, Luraschi D, De Giacomo C, et al. Antral web--a rare cause of vomiting and haematemesis in childhood. Australas Radiol 1985; 29:341.</a></li><li><a class="nounderline abstract_t">Smith TF, Welch TR, Allen JB, Sondheimer JM. Cutaneous mastocytosis with bleeding: probable heparin effect. Cutis 1987; 39:241.</a></li><li><a class="nounderline abstract_t">Bulstrode NW, Cuckow PM, Spitz LS. Neonatal gastrointestinal pseudohaemorrhage. J R Coll Surg Edinb 1998; 43:355.</a></li><li><a class="nounderline abstract_t">Rosenthal P, Thompson J, Singh M. Detection of occult blood in gastric juice. J Clin Gastroenterol 1984; 6:119.</a></li><li><a class="nounderline abstract_t">Mills RW, Burke S. Gastrointestinal bleeding in a 15 month old male. A presentation of Munchausen's syndrome by proxy. Clin Pediatr (Phila) 1990; 29:474.</a></li><li><a class="nounderline abstract_t">Thomson MA, Leton N, Belsha D. Acute upper gastrointestinal bleeding in childhood: development of the Sheffield scoring system to predict need for endoscopic therapy. J Pediatr Gastroenterol Nutr 2015; 60:632.</a></li><li><a class="nounderline abstract_t">Freedman SB, Stewart C, Rumantir M, Thull-Freedman JD. Predictors of clinically significant upper gastrointestinal hemorrhage among children with hematemesis. J Pediatr Gastroenterol Nutr 2012; 54:737.</a></li><li><a class="nounderline abstract_t">Berezin SH, Bostwick HE, Halata MS, et al. Gastrointestinal bleeding in children following ingestion of low-dose ibuprofen. J Pediatr Gastroenterol Nutr 2007; 44:506.</a></li><li><a class="nounderline abstract_t">Edwards EA, Lee MM, Acord MR, Courtier J. Abdominal Applications of Pediatric Body MR Angiography: Tailored Optimization for Successful Outcome. AJR Am J Roentgenol 2020; 215:206.</a></li><li><a class="nounderline abstract_t">Williams J, Vasanawala SS. Active gastrointestinal hemorrhage identification by blood pool contrast-enhanced magnetic resonance angiography. Pediatr Radiol 2011; 41:1198.</a></li><li><a class="nounderline abstract_t">Aarts R, Ijland MM, de Blaauw I, et al. Severe gastrointestinal tract bleeding in a two-month-old infant due to congenital intrahepatic arterioportal fistula. Eur J Radiol 2006; 59:25.</a></li><li><a class="nounderline abstract_t">Gilbert DA, Saunders DR. Iced saline lavage does not slow bleeding from experimental canine gastric ulcers. Dig Dis Sci 1981; 26:1065.</a></li><li><a class="nounderline abstract_t">Mas E, Borrelli O, Broekaert I, et al. Drugs in Focus: Octreotide Use in Children With Gastrointestinal Disorders. J Pediatr Gastroenterol Nutr 2022; 74:1.</a></li><li><a class="nounderline abstract_t">Lam JC, Aters S, Tobias JD. Initial experience with octreotide in the pediatric population. Am J Ther 2001; 8:409.</a></li><li><a class="nounderline abstract_t">Eroglu Y, Emerick KM, Whitingon PF, Alonso EM. Octreotide therapy for control of acute gastrointestinal bleeding in children. J Pediatr Gastroenterol Nutr 2004; 38:41.</a></li><li><a class="nounderline abstract_t">Imperiale TF, Birgisson S. Somatostatin or octreotide compared with H2 antagonists and placebo in the management of acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis. Ann Intern Med 1997; 127:1062.</a></li><li><a class="nounderline abstract_t">O'Meara M, Cicalese MP, Bordugo A, et al. Successful use of long-acting octreotide for intractable chronic gastrointestinal bleeding in children. J Pediatr Gastroenterol Nutr 2015; 60:48.</a></li><li><a class="nounderline abstract_t">Shneider BL, Bosch J, de Franchis R, et al. Portal hypertension in children: expert pediatric opinion on the report of the Baveno v Consensus Workshop on Methodology of Diagnosis and Therapy in Portal Hypertension. Pediatr Transplant 2012; 16:426.</a></li><li><a class="nounderline abstract_t">Goenka AS, Dasilva MS, Cleghorn GJ, et al. Therapeutic upper gastrointestinal endoscopy in children: an audit of 443 procedures and literature review. J Gastroenterol Hepatol 1993; 8:44.</a></li><li><a class="nounderline abstract_t">Balsells F, Wyllie R, Kay M, Steffen R. Use of conscious sedation for lower and upper gastrointestinal endoscopic examinations in children, adolescents, and young adults: a twelve-year review. Gastrointest Endosc 1997; 45:375.</a></li><li><a class="nounderline abstract_t">Chang MH, Wang TH, Hsu JY, et al. Endoscopic examination of the upper gastrointestinal tract in infancy. Gastrointest Endosc 1983; 29:15.</a></li><li><a class="nounderline abstract_t">Thakkar K, El-Serag HB, Mattek N, Gilger MA. Complications of pediatric EGD: a 4-year experience in PEDS-CORI. Gastrointest Endosc 2007; 65:213.</a></li><li><a class="nounderline abstract_t">Mahoney LB, Lightdale JR. Sedation of the pediatric and adolescent patient for GI procedures. Curr Treat Options Gastroenterol 2007; 10:412.</a></li><li><a class="nounderline abstract_t">Cano I, Urruzuno P, Medina E, et al. Treatment of esophageal varices by endoscopic ligation in children. Eur J Pediatr Surg 1995; 5:299.</a></li><li><a class="nounderline abstract_t">Fox VL, Carr-Locke DL, Connors PJ, Leichtner AM. Endoscopic ligation of esophageal varices in children. J Pediatr Gastroenterol Nutr 1995; 20:202.</a></li><li><a class="nounderline abstract_t">Price MR, Sartorelli KH, Karrer FM, et al. Management of esophageal varices in children by endoscopic variceal ligation. J Pediatr Surg 1996; 31:1056.</a></li><li><a class="nounderline abstract_t">Sasaki T, Hasegawa T, Nakajima K, et al. Endoscopic variceal ligation in the management of gastroesophageal varices in postoperative biliary atresia. J Pediatr Surg 1998; 33:1628.</a></li></ol></div><div id="topicVersionRevision">Topic 5857 Version 33.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10233176" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Upper gastrointestinal hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20473658" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Clinical features and risk factors for upper gastrointestinal bleeding in children: a case-crossover study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1424693" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Prevalence of, and risk factors for, upper gastrointestinal tract bleeding in critically ill pediatric patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1729041" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Frequency of upper gastrointestinal bleeding in a pediatric intensive care unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1643886" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Frequency and prophylaxis of upper gastrointestinal hemorrhage in critically ill children: a prospective study comparing the efficacy of almagate, ranitidine, and sucralfate. The Gastrointestinal Hemorrhage Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/312485" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Upper gastrointestinal bleeding in children and adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1853712" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : A clinical study of upper gastrointestinal endoscopy in Japanese children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8045755" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Upper gastrointestinal endoscopy in the pediatric patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8912124" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Gastrointestinal bleeding in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7721369" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Diagnostic upper GI endoscopy for hemetemesis in children: experience from a pediatric gastroenterology centre in north India.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9694115" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Gastrointestinal manifestations of vascular anomalies in childhood: varied etiologies require multiple therapeutic modalities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10752017" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Gastrointestinal bleeding in infancy and childhood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2914415" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Ulcerative esophagitis. A rare source of upper gastrointestinal bleeding in a neonate. Use of fiberoptic endoscopy for diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1536578" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Dexamethasone treatment during ventilator dependency: possible life threatening gastrointestinal complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9069237" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Haemorrhage from a duodenal ulcer in a neonate</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8147368" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Severe upper gastrointestinal bleeding in healthy full-term neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1479465" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Acute hemorrhagic gastritis in the newborn infant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8819562" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Fatal haemorrhagic gastritis associated with oral sulindac treatment for patent ductus arteriosus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8787482" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Bleeding esophageal duplication detected in utero.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8071760" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Prenatal gastrointestinal bleeding caused by esophagitis and gastritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6973133" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Gastric teratoma: unusual cause for bleeding of the upper gastrointestinal tract in the newborn.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3491893" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Gastric teratoma with gastrointestinal bleeding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9574773" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Isolated cavernous hemangioma of the stomach in a neonate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6602682" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Diffuse neonatal hemangiomatosis with severe gastrointestinal involvement. Favorable response to steroid therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24891598" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Gastrointestinal bleeding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9481641" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Antral duplication cyst: a cause of hypergastrinemia, recurrent peptic ulceration, and hemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35045558" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Gastrointestinal Bleeding as Initial Presentation of Intestinal Duplication.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19167582" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : The evaluation and management of neonatal coagulation disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21502830" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Management of button battery-induced hemorrhage in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22481689" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Portal vein thrombosis in children and adolescents: 20 years experience of a pediatric hepatology reference center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8885358" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Endoscopic band ligation of a Dieulafoy lesion in the small intestine of a child.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20871413" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Dieulafoy's lesion in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25859824" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Gastrointestinal Infantile Hemangioma: Presentation and Management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7807347" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Aortoesophageal fistula: congenital and acquired causes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7119960" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Hereditary hemorrhagic telangiectasia causing hematemesis in an infant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7226701" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Perinatal hemorrhage associated with the Kassabach-Merritt syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1522469" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Gastroduodenal duplication.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4539710" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Successful treatment of massive intestinal hemorrhage due to hookworm infection in a neonate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3872934" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Hemorrhagic complications of Henoch-Schönlein syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22868685" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Annular pancreas: a rare cause of upper gastrointestinal bleeding in a child.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8381865" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Duodenal web presenting with gastrointestinal bleeding in a seven-month-old infant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3835968" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Antral web--a rare cause of vomiting and haematemesis in childhood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2435463" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Cutaneous mastocytosis with bleeding: probable heparin effect.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9803113" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Neonatal gastrointestinal pseudohaemorrhage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6715849" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Detection of occult blood in gastric juice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2208908" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Gastrointestinal bleeding in a 15 month old male. A presentation of Munchausen's syndrome by proxy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25539193" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Acute upper gastrointestinal bleeding in childhood: development of the Sheffield scoring system to predict need for endoscopic therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22108337" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Predictors of clinically significant upper gastrointestinal hemorrhage among children with hematemesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17414151" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Gastrointestinal bleeding in children following ingestion of low-dose ibuprofen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32374667" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Abdominal Applications of Pediatric Body MR Angiography: Tailored Optimization for Successful Outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21594539" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Active gastrointestinal hemorrhage identification by blood pool contrast-enhanced magnetic resonance angiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16704913" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Severe gastrointestinal tract bleeding in a two-month-old infant due to congenital intrahepatic arterioportal fistula.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7307852" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Iced saline lavage does not slow bleeding from experimental canine gastric ulcers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34508049" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Drugs in Focus: Octreotide Use in Children With Gastrointestinal Disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11704779" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Initial experience with octreotide in the pediatric population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14676593" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Octreotide therapy for control of acute gastrointestinal bleeding in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9412308" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Somatostatin or octreotide compared with H2 antagonists and placebo in the management of acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25162361" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Successful use of long-acting octreotide for intractable chronic gastrointestinal bleeding in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22409296" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Portal hypertension in children: expert pediatric opinion on the report of the Baveno v Consensus Workshop on Methodology of Diagnosis and Therapy in Portal Hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8439662" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Therapeutic upper gastrointestinal endoscopy in children: an audit of 443 procedures and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9165318" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Use of conscious sedation for lower and upper gastrointestinal endoscopic examinations in children, adolescents, and young adults: a twelve-year review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6600694" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Endoscopic examination of the upper gastrointestinal tract in infancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17258979" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Complications of pediatric EGD: a 4-year experience in PEDS-CORI.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17897579" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Sedation of the pediatric and adolescent patient for GI procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8555136" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Treatment of esophageal varices by endoscopic ligation in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7714687" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Endoscopic ligation of esophageal varices in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8863233" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Management of esophageal varices in children by endoscopic variceal ligation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9856881" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Endoscopic variceal ligation in the management of gastroesophageal varices in postoperative biliary atresia.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
